Citations

Showing 10 of 108104 citations.

Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study
Robbin, Michelle L. , Greene, Tom , Allon, Michael , Dember, Laura M. , Imrey, Peter B. , Cheung, Alfred K. , Kaufman, James S. , Radeva, Milena , Shiu, Yan-Ting , Vazquez, Miguel A. , Umphrey, Heidi , Alexander, Lauren F. , Abts, C., Beck, Gerald J. , Kusek, John W., Feldman, Harold I. , Group, the Hemodialysis Fistula Maturation Study, Alexander, Lauren, Alexander, Lauren F , Greene, Tom , Himmelfarb, Jonathan , Huber, Thomas S. , Roy‐Chaudhury, Prabir , Group, the Hemodialysis Fistula Maturation Study

Mayo Clinic

Journal of the American Society of Nephrology | October 11, 2018 | Volume: 29 | Issue: 11 | Pages: 2735-2744

10.1681/asn.2017111225 | PMID 30309898 Get It

Background The utility of early postoperative ultrasound measurements in predicting arteriovenous fistula (AVF) clinical maturation is uncertain. Methods We investigated the relationships of ultrasound parameters with AVF clinical maturation in newly created AVF, measured at 1 day and 2 and 6 weeks, in 602 participants of a multicenter, observational cohort study. A backward elimination algorithm identified ultrasound measurements that independently predicted unassisted and overall AVF maturation. Candidate variables included AVF blood flow, diameter, and depth, upper arm arterial diameter, presence of stenosis, presence of accessory veins, seven case-mix factors (age, sex, black race, AVF location, diabetes, dialysis status, and body mass index), and clinical center. We evaluated the accuracy of the resulting models for clinical prediction. Results At each ultrasound measurement time, AVF blood flow, diameter, and depth each predicted in a statistically significant manner both unassisted and overall clinical maturation. Moreover, neither the remaining ultrasound parameters nor case-mix factors were associated with clinical AVF maturation after accounting for blood flow, diameter, and depth, although maturation probabilities differed among clinical centers before and after accounting for these parameters. The crossvalidated area under the receiver operating characteristic curve for models constructed using these three ultrasound parameters was 0.69, 0.74, and 0.79 at 1 day and 2 and 6 weeks, respectively, for unassisted AVF clinical maturation and 0.69, 0.71, and 0.76, respectively, for overall AVF maturation. Conclusions AVF blood flow, diameter, and depth moderately predicted unassisted and overall AVF clinical maturation. The other factors considered did not further improve AVF maturation prediction.
Enhanced recovery after surgery in gynecologic oncology
Dowdy, Sean C. , Peedicayil, Abraham , Glaser, Gretchen

Mayo Clinic

International Journal of Gynecology & Obstetrics | October 11, 2018 | Volume: 143 | Issue: S2 | Pages: 143-146

10.1002/ijgo.12622 | PMID 30306585 Get It

AbstractEnhanced recovery protocols consist of a bundle of concepts including early feeding, opioid‐sparing multimodal pain management, and euvolemia, with the overarching goal of hastening postoperative recovery. Enhanced recovery after surgery has been shown to reduce hospital length of stay, reduce costs, and decrease perioperative opioid requirements in benign and oncologic gynecologic surgery. Interventions without supporting evidence of benefit, such as the use of mechanical bowel preparation, routine use of nasogastric tubes and surgical drains, caloric restriction, routine use of intravenous opioid analgesics, and over‐vigorous intravenous hydration should be discouraged to improve broader endpoints such as patient satisfaction and overall recovery. Successful implementation requires engagement from a multidisciplinary team including surgeons, anesthesiologists, nurses, and pharmacists.
Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters
Xue, Weiwei , Fu, Tingting , Zheng, Guoxun , Tu, Gao, Zhang, Yang , Yang, Fengyuan , Tao, Lin , Yao, Lixia , Zhu, Feng , Fu, Tommy

Mayo Clinic

Current Medicinal Chemistry | October 11, 2018 | Volume: 27 | Issue: 23 | Pages: 3830-3876

10.2174/0929867325666181009123218 | PMID 30306851 Get It

Background: The human Monoamine Transporters (hMATs), primarily including hSERT, hNET and hDAT, are important targets for the treatment of depression and other behavioral disorders with more than the availability of 30 approved drugs. Objective: This paper is to review the recent progress in the binding mode and inhibitory mechanism of hMATs inhibitors with the central or allosteric binding sites, for the benefit of future hMATs inhibitor design and discovery. The Structure-Activity Relationship (SAR) and the selectivity for hit/lead compounds to hMATs that are evaluated by in vitro and in vivo experiments will be highlighted. Methods: PubMed and Web of Science databases were searched for protein-ligand interaction, novel inhibitors design and synthesis studies related to hMATs. Results: Literature data indicate that since the first crystal structure determinations of the homologous bacterial Leucine Transporter (LeuT) complexed with clomipramine, a sizable database of over 100 experimental structures or computational models has been accumulated that now defines a substantial degree of structural variability hMATs-ligands recognition. In the meanwhile, a number of novel hMATs inhibitors have been discovered by medicinal chemistry with significant help from computational models. Conclusion: The reported new compounds act on hMATs as well as the structures of the transporters complexed with diverse ligands by either experiment or computational modeling have shed light on the poly-pharmacology, multimodal and allosteric regulation of the drugs to transporters. All of the studies will greatly promote the Structure-Based Drug Design (SBDD) of structurally novel scaffolds with high activity and selectivity for hMATs.
What We Do: Povidone-Iodine Solution to Delineate the Cutaneous Roll
Gillis, Joshua A. , Bezuhly, Michael , Gillis, Joshua , Bezuhly, Michael , Morzycki, Alexander D.

Mayo Clinic

The Cleft Palate Craniofacial Journal | October 11, 2018 | Volume: 56 | Issue: 5 | Pages: 697-698

10.1177/1055665618805883 | PMID 30304949 Get It

Background: Establishing continuity of the cutaneous roll is critical to cleft lip repair. Unfortunately, this landmark can be difficult to appreciate depending on the patient’s skin tone, surgical lighting, or preexisting scar. Solution: When applied to the lip, dilute povidone-iodine solution beads off the cutaneous roll and dry vermilion, clearly defining these structures. What We Do: We use dilute povidone-iodine solution not only to prep the lip but to delineate landmarks critical to cleft lip repair.
Updates and novel treatments in urothelial carcinoma
Hanna, Kirollos S.

Mayo Clinic

Journal of Oncology Pharmacy Practice | October 11, 2018 | Volume: 25 | Issue: 3 | Pages: 648-656

10.1177/1078155218805141 | PMID 30304985 Get It

Urothelial Carcinoma (UC) is the second most common malignancy of the genitourinary system and is the sixth most common cancer in the USA. Over a decade prior to 2016, the standard of care for early disease consisted of transuretheral resection of the bladder tumor with or without intravesicular chemotherapy or immunotherapy. Systemic chemotherapies such as gemcitabine and cisplatin combinations or dose-dense methotrexate, vinblastine, doxorubicin, cisplatin were reserved for recurrent, muscle-invasive, advanced or metastatic disease. Novel treatment approaches for UC have significantly impacted the management of patients. In 2016–2017, five immune checkpoint inhibitors marked a new paradigm in the treatment of UC for patients with advanced or metastatic disease or who are unable to tolerate platinum-based chemotherapy. Most recently, the U.S. Food and Drug Administration set restrictions on two commonly utilized checkpoint inhibitors, atezolizumab and pembrolizumab, in the first-line setting in patients with UC due to decreased survival associated with low expression of the protein programmed death ligand 1. Furthermore, Breakthrough Therapy Designations have been granted for enfortumab vedotin and erdafitinib for patients following platinum-based chemotherapy and those with fibroblast growth factor receptor mutated UC, respectively. Additional updates include dose-dense gemcitabine and cisplatin for muscle-invasive bladder cancer and preoperative checkpoint blockade. This article will review the available data on updates in the treatment of UC and future direction of therapies.
A model predicting short-term mortality in patients with advanced liver cirrhosis and concomitant infection
Chaiteerakij, Roongruedee , Kwon, Jung Hyun , Cha, Stephen, Ding, Xi Wei, Ha, Fu Shuang, Nie, Cai, Giama, Nasra H., Roberts, Lewis R. , Han, Tao , Jang, Jeong Won , Roberts, Lewis R , Li, Ying , Chaiteerakij, Roongruedee , Lee, Hae Lim , Thongprayoon, Charat , Ha, Fushuang , Nie, Cai Yun, Zhang, Qian Yun , Yang, Zhen

Mayo Clinic

Medicine | October 10, 2018 | Volume: 97 | Issue: 41 | Pages: e12758

10.1097/md.0000000000012758 | PMID 30313084 Get It

Abstract Infection is a common cause of death in patients with advanced cirrhosis. We aimed to develop a predictive model in Child–Turcotte–Pugh (CTP) class C cirrhotics hospitalized with infection for optimizing treatment and improving outcomes. Clinical information was retrospectively abstracted from 244 patients at Tianjin Third Central Hospital, China (cohort 1). Factors associated with mortality were determined using logistic regression. The model for predicting 90-day mortality was then constructed by decision tree analysis. The model was further validated in 91 patients at Mayo Clinic, Rochester, MN (cohort 2) and 82 patients at Seoul St. Mary's Hospital, Korea (cohort 3). The predictive performance of the model was compared with that of the CTP, model for end-stage liver disease (MELD), MELD-Na, Chronic Liver Failure–Sequential Organ Failure Assessment, and the North American consortium for the Study of End-stage Liver Disease (NACSELD) models. The 3-month mortality was 58%, 58%, and 54% in cohort 1, 2, and 3, respectively. In cohort 1, respiratory failure, renal failure, international normalized ratio, total bilirubin, and neutrophil percentage were determinants of 3-month mortality, with odds ratios of 16.6, 3.3, 2.0, 1.1, and 1.03, respectively (P < .05). These parameters were incorporated into the decision tree model, yielding area under receiver operating characteristic (AUROC) of 0.804. The model had excellent reproducibility in the U.S. (AUROC 0.808) and Korea cohort (AUROC 0.809). The proposed model has the highest AUROC and best Youden index of 0.488 and greatest overall correctness of 75%, compared with other models evaluated. The proposed model reliably predicts survival of advanced cirrhotics with infection in both Asian and U.S. populations.
Thoracic Volumes Correlated With Pulmonary Function Tests in Adult Scoliosis Patients Following Different Treatments in Adolescence
Lee, Po-Chih, Erdman, Arthur G. , Ledonio, Charles, Polly, David W. , Larson, A. Noelle , Polly, David

Mayo Clinic

Journal of Medical Devices | October 10, 2018 | Volume: 13 | Issue: 1 | Pages: No page available

10.1115/1.4041634 Get It

In this paper, a previously developed medical software using orthogonal frontal and lateral X-rays is employed to reconstruct the rib cage and thoracic volume for scoliosis patients. The thoracic volumes of ten adult scoliosis patients with different treatments during their adolescence are followed up. This study provides an evidence that thoracic volume measurement can be used to infer the pulmonary function for spine deformity patients with moderate to severe scoliosis Cobb angle. Based on the calculation of the thoracic volumes in scoliosis patients, we correlate the parameters in the pulmonary function test to the measured thoracic volume through our software. The findings show the strong correlation between total lung capacity and the thoracic volume, and a significant correlation between the vital capacity/residual volume and the thoracic volume. An interpretation of the findings, limitation, and the future application are pointed out.
Endovascular Management of a Refractory Pseudoaneurysm of the Sternocleidomastoid Artery Caused by Attempted Internal Jugular Central Line Placement with Long-Term Follow-Up: A Case Report and Review
Abdel‐Aty, Yassmeen , Bellew, Michael P.

Mayo Clinic

Case Reports in Otolaryngology | October 10, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-4

10.1155/2018/8324908 | PMID 30405929 Get It

Introduction. This case report shows successful treatment of a refractory sternocleidomastoid branch of the superior thyroid artery (SBSTA) pseudoaneurysm using endovascular glue embolization in a patient who refused surgery. Case Presentation. A 63-year-old female with multiple comorbidities presented with a firm 7 cm tender mass located in the right neck. Ultrasound showed pseudoaneurysm and a 7 × 3.3 × 4 cm multilobular hematoma in the location of the previous central line. CTA showed a corresponding heterogeneous mass. Serial imaging demonstrated enlargement over 2 weeks. Angiogram showed contrast blush off of the SBSTA. Management and Outcome. SBSTA was embolized using glue. Repeat angiogram showed embolization and no contrast blush. One month later, the mass was no longer pulsatile but present on physical exam. CTA showed decreased size. 8 months later, her neck was soft without mass. Discussion. Pseudoaneurysms of the external carotid artery are rare and usually due to trauma. Pseudoaneurysms after central line placement are documented, but most are complications of femoral central lines. A handful of cases of superior thyroid artery pseudoaneurysms due to several etiologies are reported, but none involving the SBSTA. Therapeutic options include surveillance, compression, thrombin injection, embolization, and surgery. Endovascular management offers an alternative for patients unwilling or unable to undergo open surgery.
Loss of Renal Peritubular Capillaries in Hypertensive Patients Is Detectable by Urinary Endothelial Microparticle Levels
Santelli, Adrián, Abumoawad, Abdelrhman , Eirin, Alfonso , Ferguson, Christopher M. , Woollard, John R. , Textor, Stephen C., Puranik, Amrutesh S. , Lerman, Lilach O. , Sun, In O , Eirin, Alfonso , Puranik, Amrutesh S , Lerman, Amir

Mayo Clinic

Hypertension | October 10, 2018 | Volume: 72 | Issue: 5 | Pages: 1180-1188

10.1161/hypertensionaha.118.11766 | PMID 30354805 Get It

Hypertension, an important cause of chronic kidney disease, is characterized by peritubular capillary (PTC) loss. Circulating levels of endothelial microparticles (EMPs) reflect systemic endothelial injury. We hypothesized that systemic and urinary PTC-EMPs levels would reflect renal microvascular injury in hypertensive patients. We prospectively measured by flow cytometry renal vein, inferior vena cava, and urinary levels of EMPs in essential (n=14) and renovascular (RVH; n=24) hypertensive patients and compared them with peripheral blood and urinary levels in healthy volunteers (n=14). PTC-EMPs were identified as urinary exosomes positive for the PTC marker plasmalemmal-vesicle–associated protein. In 7 RVH patients, PTC and fibrosis were also quantified in renal biopsy, and in 18 RVH patients, PTC-EMPs were measured again 3 months after continued medical therapy with or without stenting (n=9 each). Renal vein and systemic PTC-EMPs levels were not different among the groups, whereas their urinary levels were elevated in both RVH and essential hypertension versus healthy volunteers (56.8%±12.7% and 62.8%±10.7% versus 34.0%±17.8%; both P ≤0.001). Urinary PTC-EMPs levels correlated directly with blood pressure and inversely with estimated glomerular filtration rate. Furthermore, in RVH, urinary PTC-EMPs levels correlated directly with stenotic kidney hypoxia, histological PTC count, and fibrosis and inversely with cortical perfusion. Three months after treatment, the change in urinary PTC-EMPs levels correlated inversely with a change in renal function ( r =−0.582; P =0.011). Therefore, urinary PTC-EMPs levels are increased in hypertensive patients and may reflect renal microcirculation injury, whereas systemic PTC-EMPs levels are unchanged. Urinary PTC-EMPs may be useful as novel biomarkers of intrarenal capillary loss.
Aging Alters the Relative Contributions of the Sympathetic and Parasympathetic Nervous System to Blood Pressure Control in Women
Baker, Sarah E. , Limberg, Jacqueline K. , Curry, Timothy B. , Nicholson, Wayne T. , Dillon, Gabrielle A. , Baker, Sarah E , Joyner, Michael J.

Mayo Clinic

Hypertension | October 10, 2018 | Volume: 72 | Issue: 5 | Pages: 1236-1242

10.1161/hypertensionaha.118.11550 | PMID 30354803 Get It

Autonomic support of blood pressure increases with age in humans. Large differences exist in the dose of trimethaphan (TMP) required for ganglionic blockade in young and older women. We asked whether differences in the dose of TMP required to achieve ganglionic blockade are because of differences in the relative contributions of the sympathetic and parasympathetic nervous system in control of blood pressure with age. Muscle sympathetic nerve activity (microneurography, peroneal nerve), heart rate (HR), and blood pressure were recorded before and during incremental doses of TMP camsylate until ganglionic blockade was achieved (absence of muscle sympathetic nerve activity and <5-bpm increase in HR during a valsalva maneuver; final TMP dose, 1–7 mg/min). HR variability was analyzed from the ECG waveform (WinCPRS). The dose of TMP required to achieve ganglionic blockade is positively related to basal HR variability, where women with high HR variability require a higher dose of TMP to achieve ganglionic blockade. In contrast, baseline muscle sympathetic nerve activity is inversely related with the dose of TMP required to achieve ganglionic blockade, such that women with high basal muscle sympathetic nerve activity required a lower dose of TMP. As such, the change in HR with ganglionic blockade was positively related, and the change in mean arterial pressure was inversely related, with the dose of TMP required to achieve ganglionic blockade. These data suggest loss of parasympathetic tone and increased sympathetic tone with aging contribute to the increase in blood pressure with age in women and dictate the dose of TMP that is necessary to achieve ganglionic blockade.